Software On Demand

SaaS Journal

Subscribe to SaaS Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get SaaS Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


SaaS Authors: Elizabeth White, Pat Romanski, Andy Thurai, Ed Witkovic, Simon Hill

Related Topics: Cloud Computing, SaaS Journal, Biotech News Journal, Pharmaceutical News, Software Configuration Management

News Feed Item

etrials Worldwide Introduces New eClinical Capabilities At DIA’s 45th Annual Meeting in San Diego

etrials Worldwide, Inc. (Nasdaq: ETWC), a leading provider of adaptive eClinical solutions , today announced it is launching several of its newest eClinical capabilities, including three new eDiary devices, an all access portal environment and an on demand data export tool at this week’s Drug Information Association (DIA) Annual Meeting in San Diego, Calif.

Adding three Windows-based eDiary devices, grows etrials’ customer device options for electronic patient reported outcomes to four, including three touch screen PDAs and a ruggedized PDA phone, operating on enhanced software functionality allowing customers to tailor their eDiary solution to study requirements and budgets.

With the etrials Portal, customers gain the ability to access each of etrials’ eClinical applications -- including its electronic data capture (EDC), integrated Web interface (IWR) administrative Web interface for drug supply and randomization and eDiary data -- all from a single username and password sign-on portal environment. Therein, a host of portlets provide customized dashboard views and enable the seamless toggle between studies and eClinical solutions.

The etrials’ Data Exports on Demand tool puts the control back into the hands of clinical operations and biostatisticians by allowing them to export study data when they want it and how they want it. Accessible directly within the etrials portal, it allows users to instantly download of SAS datasets, CSV files and/or Microsoft Access database files with the click of a button.

“etrials’ latest capabilities are an extension of our best-of-breed eClinical solutions suite designed to help make the clinical trial process smarter,” said M. Denis Connaghan, Chief Executive Officer of etrials Worldwide. “Each of these new developments focus on enhancing integral parts of the clinical data management process and clearly provide research sponsors and contract research organizations with a more efficient, compliant and cost effective way to manage their clinical trials.”

etrials’ Three New eDiaries, All Access Portal and Data Exports on Demand, among other new capabilities will be demonstrated in San Diego, Calif., at the DIA’s 45 Annual Meeting, booth #1321.

About etrials(R)

Headquartered near North Carolina’s Research Triangle Park, etrials Worldwide, Inc. (Nasdaq: ETWC), is a leading provider of eClinical software and services to pharmaceutical, biotechnology, and medical device companies, as well as contract research organizations, offering adaptive, Web-based tools that work together to coordinate data capture, logistics, patient interaction and trial management – turning data into intelligence and shortening the pathway to an actionable study endpoint. etrials is one of the few top-tier solution providers that offers electronic data capture

(EDC), interactive voice and Web response (IVR/IWR) and electronic patient diaries (eDiary), as part of a flexible and integrated software-as-a-service (SaaS) platform or as individual solutions to capture high quality data from multiple pivot points to enable real-time access for informed decision-making. As an experienced leader, etrials has facilitated over 900 trials involving more than 400,000 patients in 70 countries and has participated in 42 studies that resulted in 14 approved new drug applications and/or regulatory approvals. To learn more, visit us at www.etrials.com. etwcf

Forward-Looking Statements

This announcement may contain forward-looking statements, including statements regarding the expected benefits of new capabilities developed by the Company. These statements involve risks and uncertainties. Actual results could differ materially from those discussed. Factors that could cause or contribute to such differences include, but are not limited to, utilization of our software and services by clients to a lesser degree than is currently expected and early termination of the projects, all of which are possible because our agreements do not generally have minimum volume guarantees and can be terminated without penalty by clients. More information about potential factors which could cause actual results to differ from the forward-looking statements included in this announcement is included in our filings with the Securities and Exchange Commission, including the "Risk Factors" Section of the Form 10-K filed on March 10, 2009. All forward-looking statements are based on information available to us on the date hereof, and we assume no obligation to update such statements.

etrials® is the registered trademark in the United States of etrials Worldwide, Inc. Other marks belong to their respective owners and are used with permission.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.